Primary prevention of cardiovascular disease in pre-diabetes: the glass is half full and half empty.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

1. Coronary Flow Reserve and Glycemic Variability in Patients with Coronary Artery Disease.Internal medicine (Tokyo, Japan) · 2021
   Article
2. Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study.Annals of translational medicine · 2020
   Article
3. Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.Endocrinology and metabolism clinics of North America · 2018
   Review
4. Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications.Experimental biology and medicine (Maywood, N.J.) · 2016 · on this map
   Review
5. Prediabetes as a therapeutic target.Clinical chemistry · 2011
   Review
6. Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2010
   Review
7. eNOS, metabolic syndrome and cardiovascular disease.Trends in endocrinology and metabolism: TEM · 2009
   Review
8. Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.The Journal of clinical endocrinology and metabolism · 2009
   Article

Corrections and comments

• Comment on
  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.2005

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as